Gergely Varga

412 total citations
40 papers, 239 citations indexed

About

Gergely Varga is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Gergely Varga has authored 40 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 22 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Gergely Varga's work include Multiple Myeloma Research and Treatments (23 papers), Protein Degradation and Inhibitors (15 papers) and Peptidase Inhibition and Analysis (5 papers). Gergely Varga is often cited by papers focused on Multiple Myeloma Research and Treatments (23 papers), Protein Degradation and Inhibitors (15 papers) and Peptidase Inhibition and Analysis (5 papers). Gergely Varga collaborates with scholars based in Hungary, Germany and Sweden. Gergely Varga's co-authors include Tamás Masszi, Gábor Mikala, Péter Farkas, Judit Várkonyi, Judit Kiss, Katalin Pálóczi, Ferenc Uher, Virág Vas, László Gopcsa and Hajnalka Andrikovics and has published in prestigious journals such as Blood, British Journal of Haematology and Value in Health.

In The Last Decade

Gergely Varga

33 papers receiving 238 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gergely Varga Hungary 10 154 121 79 51 23 40 239
Anna Christoforidou Greece 10 100 0.6× 65 0.5× 52 0.7× 55 1.1× 15 0.7× 29 227
Federico Vozella Italy 10 162 1.1× 82 0.7× 78 1.0× 81 1.6× 8 0.3× 31 241
Monica Castelli Italy 5 105 0.7× 94 0.8× 44 0.6× 50 1.0× 19 0.8× 7 235
Christos Poziopoulos Greece 10 186 1.2× 118 1.0× 95 1.2× 81 1.6× 29 1.3× 19 259
Özgür Mehtap Türkiye 11 73 0.5× 68 0.6× 58 0.7× 51 1.0× 34 1.5× 34 257
Manuela Rizzo Italy 7 186 1.2× 133 1.1× 110 1.4× 68 1.3× 112 4.9× 28 378
John Townsend United Kingdom 3 125 0.8× 188 1.6× 53 0.7× 65 1.3× 25 1.1× 3 294
Ghaith Abu‐Zeinah United States 7 98 0.6× 96 0.8× 31 0.4× 145 2.8× 19 0.8× 44 254
Dina Sameh Soliman Qatar 8 87 0.6× 42 0.3× 42 0.5× 83 1.6× 52 2.3× 65 208
Yulia Volchek Israel 9 204 1.3× 28 0.2× 81 1.0× 99 1.9× 52 2.3× 29 285

Countries citing papers authored by Gergely Varga

Since Specialization
Citations

This map shows the geographic impact of Gergely Varga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gergely Varga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gergely Varga more than expected).

Fields of papers citing papers by Gergely Varga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gergely Varga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gergely Varga. The network helps show where Gergely Varga may publish in the future.

Co-authorship network of co-authors of Gergely Varga

This figure shows the co-authorship network connecting the top 25 collaborators of Gergely Varga. A scholar is included among the top collaborators of Gergely Varga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gergely Varga. Gergely Varga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vida, András, Gergely Varga, Emese Mihály, et al.. (2025). Gastrointestinalis amyloidosis – retrospektív elemzés egy budapesti centrum adatai alapján. Orvosi Hetilap. 166(9). 351–358.
2.
3.
Tóth, András Dávid, Laura Horváth, Péter Farkas, et al.. (2024). Myeloma multiplexben szenvedő betegek túlélési eredményei a Semmelweis Egyetem Belgyógyászati és Hematológiai Klinikáján. Orvosi Hetilap. 165(39). 1539–1547.
4.
Horváth, Róbert, et al.. (2023). Soluble B-cell maturation antigen as a monitoring marker for multiple myeloma. Pathology & Oncology Research. 29. 1611171–1611171. 13 indexed citations
5.
Tóth, András Dávid, et al.. (2023). Venetoclaxalapú mentőkezelés (11;14)-transzlokációs myeloma multiplexben az első vonalbeli kezelésre adott nem megfelelő válasz esetén. Orvosi Hetilap. 164(23). 894–899. 3 indexed citations
6.
Tóth, Gábor, Gábor László Sándor, Cecília Czakó, et al.. (2022). Corneal Densitometry and In Vivo Confocal Microscopy in Patients with Monoclonal Gammopathy—Analysis of 130 Eyes of 65 Subjects. Journal of Clinical Medicine. 11(7). 1848–1848. 4 indexed citations
7.
Révész, Katalin, Gergely Varga, Péter Farkas, et al.. (2022). Cardiac Amyloidosis with Normal Wall Thickness: Prevalence, Clinical Characteristics and Outcome in a Retrospective Analysis. Biomedicines. 10(7). 1765–1765. 9 indexed citations
8.
Varga, Gergely, et al.. (2022). Pomalidomide Treatment in Relapsed/Refractory Multiple Myeloma Patients—Real-World Data From Hungary. Pathology & Oncology Research. 28. 1610645–1610645. 2 indexed citations
9.
Tóth, András Dávid, Katalin Révész, Gergely Varga, et al.. (2022). Szívamyloidosisban a bal kamrai falvastagodás sokkal gyakrabban látott eltérés, mint a típusosnak gondolt EKG-jelek. 52(5-6). 401–408. 1 indexed citations
10.
Mikala, Gábor, Péter Rajnics, Zsolt Nagy, et al.. (2022). Targeted Venetoclax Therapy in t(11;14) Multiple Myeloma: Real World Data From Seven Hungarian Centers. Pathology & Oncology Research. 28. 1610276–1610276. 11 indexed citations
11.
Tóth, Gábor, Gábor László Sándor, Cecília Czakó, et al.. (2021). Ocular Signs and Ocular Comorbidities in Monoclonal Gammopathy: Analysis of 80 Subjects. Journal of Ophthalmology. 2021. 1–8. 2 indexed citations
12.
Kaló, Zoltán, István Vályi‐Nagy, Gergely Varga, et al.. (2020). PPM6 EARLY PHASE ECONOMIC EVALUATION OF NEW GENERATION SEQUENCE DIAGNOSTICS IN MULTIPLE MYELOMA. Value in Health. 23. S326–S327. 1 indexed citations
13.
Varga, Gergely, Zsolt Nagy, Judit Demeter, et al.. (2019). Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program. Pathology & Oncology Research. 25(4). 1615–1620. 17 indexed citations
14.
Varga, Gergely, Gábor Mikala, László Gopcsa, et al.. (2018). Multiple Myeloma of the Central Nervous System: 13 Cases and Review of the Literature. Journal of Oncology. 2018. 1–7. 28 indexed citations
15.
Varga, Gergely, Gábor Mikala, András Bors, et al.. (2017). The adverse effect of FOPNL genomic variant is reversed by bortezomib-based treatment protocols in multiple myeloma. Leukemia & lymphoma. 59(3). 710–716. 1 indexed citations
16.
Varga, Gergely, Gábor Mikala, Edit Szabó, et al.. (2017). Proteasome Subunit Beta Type 1 P11A Polymorphism Is a New Prognostic Marker in Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 17(11). 734–742. 8 indexed citations
17.
Varga, Gergely, et al.. (2015). False Positive FDG-PET Scan Caused by Uterine Leiomyoma. Journal of Cytology & Histology. 6(6). 1 indexed citations
18.
Varga, Gergely, et al.. (2010). Molecular diagnosis and therapeutic measures in patients with dyskeratosis congenita. Orvosi Hetilap. 151(8). 285–292. 1 indexed citations
19.
Kovács, Margit, Ágnes F. Semsei, András Falus, et al.. (2009). Comparative analysis of IL6 promoter and receptor polymorphisms in myelodysplasia and multiple myeloma. Leukemia Research. 33(11). 1570–1573. 18 indexed citations
20.
Varga, Gergely, Judit Kiss, Judit Várkonyi, et al.. (2007). Inappropriate notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes. Pathology & Oncology Research. 13(4). 311–319. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Christoforidou Breakdown of academic impact, for papers by Federico Vozella Breakdown of academic impact, for papers by Monica Castelli Breakdown of academic impact, for papers by Christos Poziopoulos Breakdown of academic impact, for papers by Özgür Mehtap Breakdown of academic impact, for papers by Manuela Rizzo Breakdown of academic impact, for papers by John Townsend Breakdown of academic impact, for papers by Ghaith Abu‐Zeinah Breakdown of academic impact, for papers by Dina Sameh Soliman Breakdown of academic impact, for papers by Yulia Volchek
Rankless by CCL
2026